Â鶹ŮÓÅ

The 2024 election still has big implications for health-care access and affordability. Yet both parties are moving away from their past extremes on the ACA. After a decade and a half of partisan wrangling, Obamacare won. (9/17)

Inquiring minds ask, first, whether religious beliefs that conflict with science should trump the risk of unvaccinated kids infecting their peers. Answering that question careens into another uncomfortable fact for anti-vaxxers and the vaccine-hesitant: No major religion opposes vaccination. (Rich Barlow, 9/16)

In 2017, at the age of 42, Susan Whitehead was diagnosed with an early form of breast cancer after discovering a lump in her breast. She embarked on a challenging path of treatment, including a recurrence with stage 2 cancer four years later. (Lisa Bailey, 9/18)

At the recent annual International AIDS Conference, a startling presentation about the newest wonder drug in HIV prevention brought a raucous standing ovation. Lenacapavir, a novel drug given as an injection under the skin every six months, was 100% successful in preventing HIV in adolescent girls and young women in two countries in Africa. (Mark Siedner and Rochelle Walensky, 9/18)

According to a growing body of re­­search, the health problems associated with sitting—heart disease and diabetes, to name two—aren’t simply the result of these extensive periods on our keisters. (Lydia Denworth, 9/17)